FDA Inspection 1011073 — Ironshore Pharmaceuticals & Development, Inc.
The FDA completed an inspection of Ironshore Pharmaceuticals & Development, Inc. on Mar 7, 2017 in Grand Cayman. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Grand Cayman (Cayman Islands)
Additional Details
Sponsor, Contract Research Organization